Leading Health and Life Sciences in Nova Scotia

BioFuture 2030

We’ve launched BioFuture 2030
An Economic Growth Plan for Nova Scotia’s Health and Life Sciences Sector

International BioPartnering Program

Learn more about the International BioPartnering Program

Latest News

BioNova Supports BIOTECanada initiatives (IRAP & SR&ED)

BioNova is supporting an initiative from BIOTECanada concerning IRAP and expediting SR&ED claims.Two programs which have become instrumental in supporting ...
Read More

NEWS

BioNova Supports BIOTECanada initiatives (IRAP & SR&ED)

BioNova is supporting an initiative from BIOTECanada concerning IRAP and expediting SR&ED claims.Two programs which have become instrumental in supporting early stage companies, namely: the Industrial Research Assistance Program (IRAP) and the Scientific Research...

News Release: ACOA announces $1.75M for four life sciences companies

See original ACOA news release here Atlantic Canada’s life sciences companies reaching global markets Businesses are commercializing products to improve lives and transform Atlantic Canada’s economy March 2, 2020 – Halifax, Nova Scotia – Atlantic Canada Opportunities...

HUDDLE: Local Startups Pitch To Fix N.S. Healthcare

See original HUDDLE article here HALIFAX—Dr. Brendan Carr, the president and CEO of the Nova Scotia Health Authority, admits the province’s health care system faces some challenging problems. Emergency room closures, doctor recruitment, high cancer rates, and a host...

EVENTS

No event found!

SOCIAL


Only one day left to get your submissions in to @RocheCanada COVID-19 Innovation Challenge. Deadline is tomorrow, Friday, April 10th. https://t.co/i8aWvUkGbd
BioNovaNS photo
Roche Canada @RocheCanada
The Roche Canada COVID-19 Innovation Challenge is a funding program to support our community in bringing forward innovative ideas to address some of the biggest challenges and issues of the #COVID19 pandemic. Submit your idea by April 10. https://t.co/qh99fpzuhW https://t.co/yHLRr7PafU

According to @GovCanHealth most PPE, including face shields, are Class I medical devices if they are represented for use for medical purposes. Meaning companies require regulatory approval!! @BioNovaNS can help NS companies navigate this process, reach out to us. https://t.co/p7VewvhQDg BioNovaNS photo

ABOUT BIONOVA

Our mandate is to:

  • LEAD the development of Health and Life Science in Nova Scotia
  • ACCELERATE companies and the business ecosystem
  • ADVOCATE for the sector and growth of Nova Scotia’s BioEconomy

OUR SECTOR STRENGTHS

  • Medical Technologies
  • Digital Health
  • Pharmaceuticals & Vaccines
  • Natural Health Products
  • BioProducts

Please visit our Sector Strengths page to learn more.

OUR ACCELERATION INITIATIVES

BioNova aims to accelerate the innovation and productivity of businesses in Nova Scotia’s bioeconomy through our Projects, Programs, Services & Events with the support of our stakeholders and funding partners.